Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

InMed Pharmaceuticals Inc. (INM) vs Sonoma Pharmaceuticals, Inc. (SNOA)

InMed Pharmaceuticals Inc. and Sonoma Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. is the larger, with a market value of $7.7M against $6.0M — 1.3× the size. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against 19.4%. InMed Pharmaceuticals Inc. has the higher net margin (0.00% vs −10.3%) and the higher return on invested capital (0.00% vs −70.0%). Across the 16 metrics below, Sonoma Pharmaceuticals, Inc. leads on 10 and InMed Pharmaceuticals Inc. on 6.

Valuation

Metric INM SNOA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.00 0.22 2.25
P/B 5.35 0.74 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 0.19 12.29
EV/Sales 0.65 (0.01) 2.56
Earnings yield (218.43%) (96.06%) (2.99%)
Free cash flow yield (151.13%) (54.36%) 0.00%

Profitability

Metric INM SNOA Drug Manufacturers Specialty & Generic median
Gross margin 26.27% 38.91% 53.94%
Operating margin 0.00% (6.41%) 0.00%
Net margin 0.00% (10.33%) 0.00%
Free cash flow margin 0.00% (12.11%) 0.00%
Return on equity (179.09%) (42.52%) (0.40%)
Return on assets (139.63%) (13.85%) (3.32%)
Return on invested capital 0.00% (69.96%) 0.00%

Growth

Metric INM SNOA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 19.38% 47.00% 10.01%
EPS growth (last fiscal year) 62.68% 32.26% —
Revenue growth, 5-year CAGR — 0.95% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INM SNOA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 1.37 2.99 2.31
Net debt to EBITDA 0.20 1.03 0.85

Dividend

Metric INM SNOA Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric INM SNOA Drug Manufacturers Specialty & Generic median
Market cap 7.69m 5.96m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack